Moderna stock downgrade: Openheimer analyst discusses why he downgraded the stock to neutral August 17, 2021 9:21 am by IWB Hartaj Singh, Oppenheimer Analyst, joins Yahoo Finance to discuss downgrading Moderna earlier this month, future outlook on the stock, and questions around booster shots. We are primarily funded by readers. Please subscribe and donate to support us! Views: